Biotech · Public company · South San Francisco, CA, US
CytomX Therapeutics, Inc.
Ticker CTMX · SEC CIK 0001501989
Track this companyFree. Adds CytomX Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials92 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline13
- CX-072Phase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- CX-072Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CX-2009Phase 2 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- CX-2009Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CX-2029Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- vemurafenibPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CX-188Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CX-2051Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CX-801Phase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
- CX-904Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 1 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- First In Human Study of CX-801 in Advanced Solid TumorsPHASE1 · RECRUITING · started Aug 28, 2024ClinicalTrials.gov NCT06462794 · fetched Nov 12, 2026
- First In Human Study of CX-2051 in Advanced Solid TumorsPHASE1 · RECRUITING · started Apr 2, 2024ClinicalTrials.gov NCT06265688 · fetched Nov 12, 2026
- A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started May 16, 2022ClinicalTrials.gov NCT05387265 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast CancerPHASE2 · COMPLETED · started Dec 29, 2020ClinicalTrials.gov NCT04596150 · fetched Nov 12, 2026
- PROCLAIM-CX-188: A Trial to Find Safe and Active Doses of an Investigational Drug CX-188 for Patients With Solid TumorsPHASE1 · WITHDRAWN · started Jan 1, 2020ClinicalTrials.gov NCT03706274 · fetched Nov 12, 2026
- PROCLAIM: CX-072-002: Study of PD-L1 Probody Therapeutic CX-072 in Combination With Other Anticancer Therapy in Adults With Solid TumorsPHASE2 · TERMINATED · started Nov 20, 2019ClinicalTrials.gov NCT03993379 · fetched Nov 12, 2026
- PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCLPHASE1_PHASE2 · COMPLETED · started Jun 15, 2018ClinicalTrials.gov NCT03543813 · fetched Nov 12, 2026
- PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jun 1, 2017ClinicalTrials.gov NCT03149549 · fetched Nov 12, 2026
- PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or LymphomasPHASE1_PHASE2 · TERMINATED · started Jan 19, 2017ClinicalTrials.gov NCT03013491 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 27, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 19, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 16, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 16, 2026 · fetched Nov 12, 2026